All In Biotech

Company · BMY

Bristol Myers Squibb

Includes drugs filed under related and acquired sponsor names. Trials are searched under: Bristol-Myers Squibb; Celgene; Juno Therapeutics, a Bristol-Myers Squibb Company; Karuna Therapeutics; Mirati Therapeutics Inc..

Last checked: Nov 20, 2026Source: Drugs@FDA, ClinicalTrials.gov

NDAs and BLAs

75

37 still marketed

Novel approvals

41

Approvals since 2021

59

Originals and new uses

Phase 3 trials

392

Registered, any status

Trials by phase

All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.

Recent approvals

Originals and efficacy supplements, newest first.

Drugs in development (38)

Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.

Open in pipeline

Recruiting Phase 3 trials

Largest first.

Marketed drugs (37)

Newest FDA action first.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.